SCHEMBL17876287

SCHEMBL17876287

c1ccc(-c2cc(-c3ccc4c(c3)-c3cc(-n5c6ccccc6c6ccccc65)ccc3CN(c3ccccc3)C4)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.41
ALDH1A1 P00352 4/20 0.41
MAPT P10636 4/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
HPGD P15428 3/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ATM Q13315 1/20 0.37
AHR P35869 1/20 0.36
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
LMNA P02545 2/20 0.35
HCRTR1 O43613 1/20 0.35
GAA P10253 1/20 0.35
EGFR P00533 1/20 0.35
DHODH Q02127 1/20 0.35
MELK Q14680 1/20 0.32
PIK3R2 O00459 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MAP4K1 Q92918 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876271 0.95 KDM4E (0.39) KDM4EALDH1A1MAPTL3MBTL1HPGD
SCHEMBL17876223 0.95 KDM4E (0.39) KDM4EALDH1A1MAPTL3MBTL1HPGD
SCHEMBL17877878 0.90 MYC (0.37) KDM4EALDH1A1MAPTL3MBTL1HPGD
SCHEMBL17876286 0.90 KDM4E (0.41) KDM4EALDH1A1MAPTL3MBTL1HPGD
SCHEMBL17876316 0.87 MAPT (0.42) KDM4EALDH1A1MAPTL3MBTL1HPGD
SCHEMBL17875885 0.86 KDM4E (0.42) KDM4EALDH1A1MAPTL3MBTL1HPGD
SCHEMBL17875777 0.85 KDM4E (0.37) KDM4EALDH1A1MAPTL3MBTL1HPGD
SCHEMBL17877910 0.85 MYC (0.35) KDM4EALDH1A1MAPTL3MBTL1HPGD
SCHEMBL17876224 0.85 MYC (0.35) KDM4EALDH1A1MAPTL3MBTL1HPGD
SCHEMBL17876314 0.84 MAPT (0.41) KDM4EALDH1A1MAPTL3MBTL1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 KDM4E 3120/4885ALDH1A1 1061/4885MAPT 2144/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 KDM4E 3120/4885ALDH1A1 1061/4885MAPT 2144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.